Urinary Glycosaminoglycans: Characterization and Quantification

Area of Science:

• Biochemistry
• Clinical Diagnostics
• Biomarker Discovery

Background:

• Urinary glycosaminoglycans (uGAGs) are increasingly recognized as valuable biomarkers.
• Their levels can aid in diagnosing conditions like mucopolysaccharidoses (MPS) and predicting treatment efficacy.
• Emerging research highlights GAGs' role in cancer and viral infections, including COVID-19.

Purpose of the Study:

• To establish reliable and accessible methods for the detection and characterization of urinary glycosaminoglycans (uGAGs).
• To support laboratory workers and clinicians with robust assay protocols for uGAG analysis.
• To advance the utility of uGAGs as diagnostic and prognostic biomarkers.

Main Methods:

• Development of a semiquantitative and quantitative assay for uGAG determination using 1,9-dimethylmethylene blue (DMB).
• Characterization of urinary GAGs profiles utilizing thin-layer chromatography (TLC).

Main Results:

• The study successfully implemented DMB-based assays for both semiquantitative and quantitative measurement of uGAGs.
• Thin-layer chromatography provided effective characterization of uGAGs composition.
• The described methods offer accessibility and reliability for laboratory use.

Conclusions:

• The developed DMB and TLC methods provide a robust framework for urinary GAG analysis.
• These accessible protocols enhance the potential of uGAGs as biomarkers in various clinical settings.
• Further application of these methods can improve diagnosis and treatment monitoring for diseases including cancers and viral infections.